These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 30891102)
1. Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors. Gonzalez-Villasana V; Rashed MH; Gonzalez-Cantú Y; Bayraktar R; Menchaca-Arredondo JL; Vazquez-Guillen JM; Rodriguez-Padilla C; Lopez-Berestein G; Resendez-Perez D Dis Markers; 2019; 2019():6852917. PubMed ID: 30891102 [TBL] [Abstract][Full Text] [Related]
2. Plasma exosome microRNAs are indicative of breast cancer. Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715 [TBL] [Abstract][Full Text] [Related]
3. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer. Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068 [TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma. Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793 [TBL] [Abstract][Full Text] [Related]
5. Detection significance of miR-3662, miR-146a, and miR-1290 in serum exosomes of breast cancer patients. Li S; Zhang M; Xu F; Wang Y; Leng D J Cancer Res Ther; 2021 Jul; 17(3):749-755. PubMed ID: 34269309 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells. Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069 [TBL] [Abstract][Full Text] [Related]
8. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097 [TBL] [Abstract][Full Text] [Related]
9. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer. Joyce DP; Kerin MJ; Dwyer RM Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104 [TBL] [Abstract][Full Text] [Related]
10. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Rodríguez-Martínez A; de Miguel-Pérez D; Ortega FG; García-Puche JL; Robles-Fernández I; Exposito J; Martorell-Marugan J; Carmona-Sáez P; Garrido-Navas MDC; Rolfo C; Ilyine H; Lorente JA; Legueren M; Serrano MJ Breast Cancer Res; 2019 Feb; 21(1):21. PubMed ID: 30728048 [TBL] [Abstract][Full Text] [Related]
11. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients. Wang M; Ji S; Shao G; Zhang J; Zhao K; Wang Z; Wu A Clin Transl Oncol; 2018 Jul; 20(7):906-911. PubMed ID: 29143228 [TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis. Shen S; Song Y; Zhao B; Xu Y; Ren X; Zhou Y; Sun Q Cell Commun Signal; 2021 Feb; 19(1):20. PubMed ID: 33618729 [TBL] [Abstract][Full Text] [Related]
13. Novel breast cancer screening: combined expression of miR-21 and MMP-1 in urinary exosomes detects 95% of breast cancer without metastasis. Ando W; Kikuchi K; Uematsu T; Yokomori H; Takaki T; Sogabe M; Kohgo Y; Otori K; Ishikawa S; Okazaki I Sci Rep; 2019 Sep; 9(1):13595. PubMed ID: 31537868 [TBL] [Abstract][Full Text] [Related]
14. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Singh R; Pochampally R; Watabe K; Lu Z; Mo YY Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807 [TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer. Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526 [TBL] [Abstract][Full Text] [Related]
16. Oncogenic miRNAs Identified in Tear Exosomes From Metastatic Breast Cancer Patients. Inubushi S; Kawaguchi H; Mizumoto S; Kunihisa T; Baba M; Kitayama Y; Takeuchi T; Hoffman RM; Tanino H; Sasaki R Anticancer Res; 2020 Jun; 40(6):3091-3096. PubMed ID: 32487603 [TBL] [Abstract][Full Text] [Related]
17. Exosomes and their miRNA/protein profile in keratoconus-derived corneal stromal cells. Hadvina R; Lotfy Khaled M; Akoto T; Zhi W; Karamichos D; Liu Y Exp Eye Res; 2023 Nov; 236():109642. PubMed ID: 37714423 [TBL] [Abstract][Full Text] [Related]
18. Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer. Zou X; Li M; Huang Z; Zhou X; Liu Q; Xia T; Zhu W Gene; 2020 Jan; 722():144104. PubMed ID: 31493506 [No Abstract] [Full Text] [Related]
19. Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer. Shi Y; Wang Z; Zhu X; Chen L; Ma Y; Wang J; Yang X; Liu Z Int J Clin Oncol; 2020 Jan; 25(1):89-99. PubMed ID: 31506750 [TBL] [Abstract][Full Text] [Related]
20. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor. Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]